The penetrance of BMPR2 mutations is age dependent and has been estimated to range between 27 % in women and 14 % in men at the time of first PAH diagnosis [16] but may be as high as 43–50 % in some families [17, 18]. Here, BMPR2 is linked to pulmonary arterial hypertension.